Recently, ACTL targeted anti-tumor cellular immune technology has entered Hainan Island and will become a new choice for people in Hainan Province to prevent and treat tumors, providing clinicians in Hainan Province with a new and effective treatment. ACTL technology landed in Hainan...

On the afternoon of November 26, accompanied by the leaders of Shenzhen Nanshan District Science and Technology Bureau, CPPCC Vice Chairman Lu Yuping led a delegation of Nanshan CPPCC committee members to visit ISKCON's headquarters to inspect and investigate the company...

On November 20, 2014, Shenzhen Yishi Kangning Biotechnology Co., Ltd. and Peking University Shenzhen Hospital (Peking University Hospital) signed a memorandum on the cooperation of ACTL anti-tumor cell immune technology. On the same day, Professor Liu Yong, Chief Scientist o...

In October 2014, Shenzhen Yishi Kangning Biotechnology Co., Ltd. passed the ISO9001:2008 quality management system certification recognized by the National Certification and Accreditation Administration Committee. Hereby, I would like to express my gratitude to friends from all wal...

After review by the experts of Shenzhen Science and Technology Innovation Committee, Yishi Kangning was included in the 2014 Shenzhen High-tech Enterprise List on October 16, becoming another high-tech enterprise in Shenzhen. Since its establishment two years ago, ISKCON has act...